A review of asymptomatic and sub-clinical Middle East Respiratory Syndrome Coronavirus Infections

Researchers conducted a review of molecular and serological investigations through PubMed and EMBASE from September 2012 to 15 November 2018 to measure sub-clinical or asymptomatic Middle East Respiratory syndrome coronavirus (MERS-CoV) infection within and outside of health care settings.

Bactrian camels shed large quantities of Middle East respiratory syndrome coronavirus (MERS-CoV) after experimental infection*

Dromedary camels play a significant part in the circulation and the zoonotic transmission of Middle East respiratory syndrome coronavirus (MERS-CoV). Researchers demonstrated that Bactrian camels are also susceptible to MERS-CoV infection and shed large quantities of infectious virus in nasal secretions. 

Comparative Analysis of Eleven Healthcare-Associated Outbreaks of Middle East Respiratory Syndrome Coronavirus (Mers-Cov) from 2015 to 2017

Researchers analyzed epidemiologic and clinical data of laboratory-confirmed Middle East respiratory syndrome coronavirus (MERS-CoV) cases from eleven healthcare-associated outbreaks in Saudi Arabia and the South Korea between 2015–2017.

MERS-CoV infection among healthcare workers and risk factors for death: Retrospective analysis of all laboratory-confirmed cases reported to WHO from 2012 to 2 June 2018

About 50 percent of reported laboratory-confirmed infections of Middle East respiratory syndrome coronavirus (MERS-CoV) have occurred in healthcare settings, with healthcare workers constituting over a third of all secondary infections.